Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6

Journal of Molecular and Cellular Cardiology

Volumn 104, Issue , 2017, Pages 43-52

  Jansen, Felix ^a   Stumpf, Tobias ^a   Proebsting, Sebastian ^a   Franklin, Bernardo S ^a   Wenzel, Daniela ^a   Pfeifer, Philipp ^a   Flender, Anna ^a   Schmitz, Theresa ^a   Yang, Xiaoyan ^b   Fleischmann, Bernd K ^a   Nickenig, Georg ^a   Werner, Nikos ^a  

^a UNIVERSITY OF BONN   (Germany)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Endothelial microparticles; Microrna 126; Vascular remodelling

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MICRORNA 126; MICRORNA; MIRN126 MICRORNA, HUMAN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BARE METAL STENTING; CELL COMMUNICATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIAL MICROPARTICLE; FEMALE; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NEOINTIMA; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN EXPRESSION; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; DISEASE MODEL; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MEMBRANE MICROPARTICLE; METABOLISM; MIDDLE AGED; PATHOLOGY; RNA INTERFERENCE; SMOOTH MUSCLE CELL; TRANSPORT AT THE CELLULAR LEVEL; VASCULAR SMOOTH MUSCLE;

AGED; ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CELL PROLIFERATION; CELL-DERIVED MICROPARTICLES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; MALE; MICE; MICE, KNOCKOUT; MICRORNAS; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; RNA INTERFERENCE;

EID: 85011584251     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2016.12.005     Document Type: Article

References (43)

1. [1] Chaabane, C., Otsuka, F., Virmani, R., Bochaton-Piallat, M.-L., Biological responses in stented arteries. Cardiovasc. Res. 99 (2013), 353–363, 10.1093/cvr/cvt115.
2. [2] Armstrong, E.J., Rutledge, J.C., Rogers, J.H., Coronary artery revascularization in patients with diabetes mellitus. Circulation 128 (2013), 1675–1685, 10.1161/CIRCULATIONAHA.113.002114.
3. [3] Jansen, F., Yang, X., Hoelscher, M., Cattelan, A., Schmitz, T., Proebsting, S., et al. Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation 128 (2013), 2026–2038, 10.1161/CIRCULATIONAHA.113.001720.
4. [4] Dzau, V.J., Braun-Dullaeus, R.C., Sedding, D.G., Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat. Med. 8 (2002), 1249–1256, 10.1038/nm1102-1249.
5. [5] Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal., 2, 2009, ra81, 10.1126/scisignal.2000610.
6. [6] Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism. J. Cell Mol. Med. 19:9 (2015), 2202–2214, 10.1111/jcmm.12607.
7. [7] Tsimerman, G., Roguin, A., Bachar, A., Melamed, E., Brenner, B., Aharon, A., Involvement of microparticles in diabetic vascular complications. Thromb. Haemost. 106 (2011), 310–321, 10.1160/TH10-11-0712.
8. [8] Weintraub, W.S., The pathophysiology and burden of restenosis. Am. J. Cardiol. 100 (2007), 3K–9K, 10.1016/j.amjcard.2007.06.002.
9. [9] Werner, N., Junk, S., Laufs, U., Link, A., Walenta, K., Böhm, M., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ. Res. 93 (2003), e17–e24, 10.1161/01.RES.0000083812.30141.74.
10. [10] Zampetaki, A., Kiechl, S., Drozdov, I., Willeit, P., Mayr, U., Prokopi, M., et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 107 (2010), 810–817, 10.1161/CIRCRESAHA.110.226357.
11. [11] Schlaweck, S., Zimmer, S., Struck, R., Bartok, E., Werner, N., Bauernfeind, F., et al. Critical role of nucleotide-binding oligomerization domain-like receptor 3 in vascular repair. Biochem. Biophys. Res. Commun. 411 (2011), 627–631, 10.1016/j.bbrc.2011.07.006.
12. [12] Dignat-George, F., Boulanger, C.M., The many faces of endothelial microparticles. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 27–33, 10.1161/ATVBAHA.110.218123.
13. [13] Libby, P., Changing concepts of atherogenesis. J. Intern. Med. 247 (2000), 349–358.
14. [14] Jansen, F., Yang, X., Franklin, B.S., Hoelscher, M., Schmitz, T., Bedorf, J., et al. High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation. Cardiovasc. Res. 98 (2013), 94–106, 10.1093/cvr/cvt013.
15. [15] Leroyer, A.S., Anfosso, F., Lacroix, R., Sabatier, F., Simoncini, S., Njock, S.M., et al. Endothelial-derived microparticles: Biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb. Haemost. 104 (2010), 456–463, 10.1160/TH10-02-0111.
16. [16] Jansen, F., Yang, X., Baumann, K., Przybilla, D., Schmitz, T., Flender, A., et al. Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism. J. Cell. Mol. Med. 19 (2015), 2202–2214, 10.1111/jcmm.12607.
17. [17] Chen, J., Chen, S., Chen, Y., Zhang, C., Wang, J., Zhang, W., et al. Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage. Am. J. Physiol. Endocrinol. Metab. 301 (2011), E62–E71, 10.1152/ajpendo.00026.2011.
18. [18] Loyer, X., Vion, A.-C., Tedgui, A., Boulanger, C.M., Microvesicles as cell-cell messengers in cardiovascular diseases. Circ. Res. 114 (2014), 345–353, 10.1161/CIRCRESAHA.113.300858.
19. [19] Diehl, P., Fricke, A., Sander, L., Stamm, J., Bassler, N., Htun, N., et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc. Res. 93 (2012), 633–644, 10.1093/cvr/cvs007.
20. [20] Schober, A., Nazari-Jahantigh, M., Wei, Y., Bidzhekov, K., Gremse, F., Grommes, J., et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat. Med. 20 (2014), 368–376, 10.1038/nm.3487.
21. [21] Fish, J.E., Santoro, M.M., Morton, S.U., Yu, S., Yeh, R.-F., Wythe, J.D., et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 15 (2008), 272–284, 10.1016/j.devcel.2008.07.008.
22. [22] Du, C., Lv, Z., Cao, L., Ding, C., Gyabaah, O.-A.K., Xie, H., et al. MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2. J. Transl. Med., 12, 2014, 259, 10.1186/s12967-014-0259-1.
23. [23] Mause, S.F., Weber, C., Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ. Res. 107 (2010), 1047–1057, 10.1161/CIRCRESAHA.110.226456.
24. [24] Keramati, A.R., Singh, R., Lin, A., Faramarzi, S., Ye, Z.-J., Mane, S., et al. Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C increases PDGF-dependent vascular smooth muscle cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 1914–1918, 10.1073/pnas.1019443108.
25. [25] Srivastava, R., Zhang, J., Go, G.-W., Narayanan, A., Nottoli, T.P., Mani, A., Impaired LRP6-TCF7L2 activity enhances smooth muscle cell plasticity and causes coronary artery disease. Cell Rep. 13 (2015), 746–759, 10.1016/j.celrep.2015.09.028.
26. [26] Wang, X., Xiao, Y., Mou, Y., Zhao, Y., Blankesteijn, W.M., Hall, J.L., A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Circ. Res. 90 (2002), 340–347.
27. [27] Wang, X., Adhikari, N., Li, Q., Hall, J.L., LDL receptor-related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 287 (2004), H2376–H2383, 10.1152/ajpheart.01173.2003.
28. [28] Sun, C., Alkhoury, K., Wang, Y.I., Foster, G.A., Radecke, C.E., Tam, K., et al. IRF-1 and miRNA126 modulate VCAM-1 expression in response to a high-fat meal. Circ. Res. 111 (2012), 1054–1064, 10.1161/CIRCRESAHA.112.270314.
29. [29] Zhao, C., Li, Y., Zhang, M., Yang, Y., Chang, L., miR-126 inhibits cell proliferation and induces cell apoptosis of hepatocellular carcinoma cells partially by targeting Sox2. Hum. Cell 28 (2015), 91–99, 10.1007/s13577-014-0105-z.
30. [30] Boon, R.A., Vickers, K.C., Intercellular transport of microRNAs. Arterioscler. Thromb. Vasc. Biol. 33 (2013), 186–192, 10.1161/ATVBAHA.112.300139.
31. [31] Dangwal, S., Thum, T., microRNA therapeutics in cardiovascular disease models. Annu. Rev. Pharmacol. Toxicol. 54 (2014), 185–203, 10.1146/annurev-pharmtox-011613-135957.
32. [32] Burnier, L., Fontana, P., Angelillo-Scherrer, A., Kwak, B.R., Intercellular communication in atherosclerosis. Physiology (Bethesda) 24 (2009), 36–44, 10.1152/physiol.00036.2008.
33. [33] Yellon, D.M., Davidson, S.M., Exosomes: nanoparticles involved in cardioprotection?. Circ. Res. 114 (2014), 325–332, 10.1161/CIRCRESAHA.113.300636.
34. [34] Hulsmans, M., Holvoet, P., MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc. Res. 100 (2013), 7–18, 10.1093/cvr/cvt161.
35. [35] Hergenreider, E., Heydt, S., Tréguer, K., Boettger, T., Horrevoets, A.J.G., Zeiher, A.M., et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat. Cell Biol. 14 (2012), 249–256, 10.1038/ncb2441.
36. [36] Zhou, J., Li, Y.-S., Nguyen, P., Wang, K.-C., Weiss, A., Kuo, Y.-C., et al. Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microRNA-126: role of shear stress. Circ. Res. 113 (2013), 40–51, 10.1161/CIRCRESAHA.113.280883.
37. [37] Jansen, F., Yang, X., Proebsting, S., Hoelscher, M., Przybilla, D., Baumann, K., et al. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J. Am. Heart Assoc., 3, 2014, e001249, 10.1161/JAHA.114.001249.
38. [38] Hoyer, F.F., Giesen, M.K., Franca, C., Lütjohann, D., Nickenig, G., Werner, N., Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice. J. Cell. Mol. Med., 2012, 10.1111/j.1582-4934.2012.01595.x.
39. [39] Bang, C., Batkai, S., Dangwal, S., Gupta, S.K., Foinquinos, A., Holzmann, A., et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J. Clin. Invest. 124 (2014), 2136–2146, 10.1172/JCI70577.
40. [40] Jansen, F., Wang, H., Przybilla, D., Franklin, B.S., Dolf, A., Pfeifer, P., et al. Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus. Cardiovasc. Diabetol., 15, 2016, 49, 10.1186/s12933-016-0367-8.
41. [41] Zampetaki, A., Willeit, P., Tilling, L., Drozdov, I., Prokopi, M., Renard, J.-M., et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J. Am. Coll. Cardiol. 60 (2012), 290–299, 10.1016/j.jacc.2012.03.056.
42. [42] de Boer, H.C., van Solingen, C., Prins, J., Duijs, J.M.G.J., Huisman, M.V., Rabelink, T.J., et al. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur. Heart J. 34 (2013), 3451–3457, 10.1093/eurheartj/eht007.
43. [43] Finn, N.A., Eapen, D., Manocha, P., Al Kassem, H., Lassegue, B., Ghasemzadeh, N., et al. Coronary heart disease alters intercellular communication by modifying microparticle-mediated microRNA transport. FEBS Lett. 587 (2013), 3456–3463, 10.1016/j.febslet.2013.08.034.